About Jeffrey Schweitzer, MD, PhD

As a board-certified neurosurgeon, Dr. Jeff Schweitzer is passionate about improving and restoring quality of life, especially for patients with Parkinson’s, epilepsy and other movement disorders.

Dr. Schweitzer has over 30 years of experience in the field. Previously, he was the Chief of Neurosurgery at Wright State University-Premier Health Partners and he ran the Epilepsy, Movement Disorder and Pituitary Surgery Programs at Kaiser Permanente Los Angeles Medical Center for 13 years.

He has also served as the Director of the Epilepsy and Functional Neurosurgery at Miami Valley Hospital in Dayton, OH. Most recently, he worked at Scripps Memorial Hospital in San Diego where he was named a top doctor by the San Diego County Medical Society.

In addition to surgery for movement disorders, Dr. Schweitzer is experienced in many areas of surgery of the brain and spine as well as radiosurgery.

Dr. Schweitzer has done extensive research on Parkinson's disease, and he speaks three languages: English, French and Mandarin Chinese.

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Languages:

Locations

Neurosurgical Associates
15 Parkman Street
Boston, MA 02114-3117
617-726-1799
Fax: 617-643-4113

Medical Education

  • PhD, Harvard Graduate School of Arts and Sciences
  • MD, Harvard Medical School
  • Residency, UCLA Center for Health Sciences
  • Fellowship, Yale University School of Medicine

American Board Certifications

  • Neurological Surgery, American Board of Neurological Surgery

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Dr. Schweitzer's current research centers on improved surgical techniques and strategies for the implantation of stem cell derived therapies to treat Parkinson's disease. His work involves both basic scientific approaches and clinical trials. 

Publications

  • Select publications:

    • Schweitzer JS, Kaufman SJ, Dichter MA. Differential expression and modulation of Thy-1 on myoblast clones. Exp Cell Res, 1987, 172: 21-31.
    • Schweitzer JS, Patrylo P, Dudek FE. Prolonged field bursts in the dentate gyrus: dependence on low calcium, high potassium and nonsynaptic interactions. J Neurophysiol, 1992, 68: 2016-2025.
    • Patrylo PR, Schweitzer JS, Dudek FE. Potassium-dependent prolonged field bursts in the dentate gyrus: Effects of extracellular calcium and amino acid receptor antagonists. Neuroscience, 1994, 61(1):13-19.
    • Schweitzer JS, Williamson A. Relationship between synaptic activity and prolonged field bursts in the rat dentate gyrus in vitro. J Neurophysiol, 1995, 74(5):1947-1952.
    • Patrylo PR., Copus, AJ, Schweitzer JS and Dudek FE. Multiple-unit recordings during slow field-potential shifts in low-[Ca2+] solutions in rat hippocampal and cortical slices. Neuroscience, 1996, 74:107-118.
    • Schweitzer JS, H Wang, Z.Q. Xiong, J.L. Stringer. pH sensitivity of non-synaptic field bursts in the rat dentate gyrus. J Neurophysiol. 2000, 84: 927-933.
    • Gurbani S, Chayasirisobhon S, Cahan L, Choi S, Enos B, Hwang J, Lin M, Schweitzer J. Neuromodulation Therapy with Vagus Nerve Stimulation for Intractable Epilepsy: A 2-Year Efficacy Analysis Study in Patients Under 12 Years of Age. Epilepsy Research and Treatment 2016: 1-5.
    • Sonntag KC, Song B, Lee N, Jung JH, Cha Y, Leblanc PR, Neff C, Carter B, Schweitzer J, Kim KS.  Personalized cell therapy for Parkinson's disease: current status and future prospects.  Prog Neurobiol 2018 (in press)